Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
0 |
24/02/22 |
24/02/22 |
Charts
|
33K
|
16M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
14 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
154
|
75K
|
14
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
EML333
|
4.9K |
2.0M |
0 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
4.9K
|
2.0M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
10 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
10 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
10
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
0 |
23/02/22 |
23/02/22 |
Charts
|
33K
|
16M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
4 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
2 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
14 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
25 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
21 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
0 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
2 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
EML333
|
154 |
75K |
10 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
154
|
75K
|
10
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
2 |
22/02/22 |
22/02/22 |
Charts
|
33K
|
16M
|
2
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
EML333
|
2.9K |
1.3M |
18 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
18
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
4 |
04/02/22 |
04/02/22 |
Charts
|
33K
|
16M
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
0 |
04/02/22 |
04/02/22 |
Charts
|
33K
|
16M
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
7 |
28/01/22 |
28/01/22 |
Charts
|
33K
|
16M
|
7
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
1 |
28/01/22 |
28/01/22 |
Charts
|
33K
|
16M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
EML333
|
2.9K |
1.3M |
1 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
1 |
25/01/22 |
25/01/22 |
Charts
|
33K
|
16M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
11 |
24/01/22 |
24/01/22 |
Charts
|
33K
|
16M
|
11
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
0 |
21/01/22 |
21/01/22 |
Charts
|
33K
|
16M
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
4 |
21/01/22 |
21/01/22 |
Charts
|
33K
|
16M
|
4
|
|
Charts
|
BRN |
Re:
Chart
|
|
EML333
|
20K |
8.0M |
1 |
21/01/22 |
21/01/22 |
Charts
|
20K
|
8.0M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
EML333
|
2.9K |
1.3M |
6 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
6
|
|
Charts
|
BRN |
Re:
Chart
|
|
EML333
|
20K |
8.0M |
8 |
20/01/22 |
20/01/22 |
Charts
|
20K
|
8.0M
|
8
|
|
ASX - By Stock
|
AN1 Biotech |
Re:
RATS
|
|
EML333
|
11 |
3.3K |
0 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
11
|
3.3K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
EML333
|
2.9K |
1.3M |
27 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
27
|
|
ASX - By Stock
|
BRN |
Re:
Ann: US Patent Granted
|
|
EML333
|
200 |
110K |
10 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
200
|
110K
|
10
|
|
ASX - By Stock
|
BRN |
Re:
Ann: US Patent Granted
|
|
EML333
|
200 |
110K |
8 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
200
|
110K
|
8
|
|
Charts
|
BRN |
Re:
Chart
|
|
EML333
|
20K |
8.0M |
11 |
18/01/22 |
18/01/22 |
Charts
|
20K
|
8.0M
|
11
|
|
Charts
|
BRN |
Re:
Chart
|
|
EML333
|
20K |
8.0M |
15 |
18/01/22 |
18/01/22 |
Charts
|
20K
|
8.0M
|
15
|
|
Charts
|
BRN |
Re:
Chart
|
|
EML333
|
20K |
8.0M |
4 |
14/01/22 |
14/01/22 |
Charts
|
20K
|
8.0M
|
4
|
|
Charts
|
BRN |
Re:
Chart
|
|
EML333
|
20K |
8.0M |
2 |
14/01/22 |
14/01/22 |
Charts
|
20K
|
8.0M
|
2
|
|
Charts
|
BRN |
Re:
BRN
|
|
EML333
|
47 |
15K |
3 |
13/01/22 |
13/01/22 |
Charts
|
47
|
15K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
BRN SHARE PRICE PREDICTION BY CHRISTMAS 2022
|
|
EML333
|
298 |
183K |
12 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
298
|
183K
|
12
|
|
Political Debate
|
|
Re:
NSW cases hit 11,201. 625 in hospital, three deaths
|
|
EML333
|
437 |
44K |
6 |
31/12/21 |
31/12/21 |
Political Debate
|
437
|
44K
|
6
|
|
Political Debate
|
|
Re:
NSW cases hit 11,201. 625 in hospital, three deaths
|
|
EML333
|
437 |
44K |
4 |
31/12/21 |
31/12/21 |
Political Debate
|
437
|
44K
|
4
|
|
Political Debate
|
|
Re:
NSW cases hit 11,201. 625 in hospital, three deaths
|
|
EML333
|
437 |
44K |
2 |
31/12/21 |
31/12/21 |
Political Debate
|
437
|
44K
|
2
|
|
Political Debate
|
|
Re:
NSW cases hit 11,201. 625 in hospital, three deaths
|
|
EML333
|
437 |
44K |
2 |
31/12/21 |
31/12/21 |
Political Debate
|
437
|
44K
|
2
|
|
Political Debate
|
|
Re:
NSW cases hit 11,201. 625 in hospital, three deaths
|
|
EML333
|
437 |
44K |
1 |
31/12/21 |
31/12/21 |
Political Debate
|
437
|
44K
|
1
|
|
Political Debate
|
|
Re:
NSW cases hit 11,201. 625 in hospital, three deaths
|
|
EML333
|
437 |
44K |
4 |
31/12/21 |
31/12/21 |
Political Debate
|
437
|
44K
|
4
|
|
ASX - By Stock
|
AMM |
Re:
Good buy @ $0.1-$0.12
|
|
EML333
|
16 |
5.9K |
2 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
16
|
5.9K
|
2
|
|
ASX - By Stock
|
AMM |
Re:
Good buy @ $0.1-$0.12
|
|
EML333
|
16 |
5.9K |
0 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
16
|
5.9K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: S&P DJI Announces December 2021 Quarterly Rebalance
|
|
EML333
|
73 |
46K |
17 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
73
|
46K
|
17
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
EML333
|
33K |
16M |
10 |
01/12/21 |
01/12/21 |
Charts
|
33K
|
16M
|
10
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
EML333
|
10K |
3.6M |
3 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
10K
|
3.6M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer
|
|
EML333
|
252 |
136K |
23 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
252
|
136K
|
23
|
|